Equity Overview
Price & Market Data
Price: $2.64
Daily Change: -$0.12 / 4.55%
Range: $2.57 - $2.76
Market Cap: $80,487,528
Volume: 72,860
Performance Metrics
1 Week: -8.97%
1 Month: -8.33%
3 Months: -20.24%
6 Months: -60.18%
1 Year: -59.94%
YTD: -33.16%
Company Details
Employees: 92
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes true human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases. The company is also developing interleukin-1 alpha therapies to various medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and general inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.